Drug Type Small molecule drug |
Synonyms KABIVEN |
Target- |
Mechanism Calcium supplements, Sodium supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (25 Aug 2014), |
Regulation- |
Molecular FormulaC2H4NaO2 |
InChIKeyBDKZHNJTLHOSDW-UHFFFAOYSA-N |
CAS Registry127-09-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Nutrition Disorders | US | 25 Aug 2014 |